Back
ESC2025 Premium Access

The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation

Session: New perspectives in cardiology (3) - Treatment and outcome of mitral valve regurgitation
Topic: Mitral Valve Regurgitation
Speaker: Doctor C. Riebel (Cluj Napoca, RO)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Catalina Ileana Riebel

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)
1 presentation
0 follower

9 more presentations in this session

Discussant - Treatment and outcome of mitral valve regurgitation

Access
Like
Thumbnail

Concomitant mitral regurgitation is associated with worse outcomes after T-TEER: insights from the EuroTR registry

Speaker: Doctor D. Felbel (Ulm, DE)

Access
Abstract
Video
Like
Thumbnail

Echocardiographic insights: factors influencing mitral regurgitation in fabry disease

Speaker: Doctor A. Vecerova (Prague, CZ)

Access
Abstract
Video
Like
Thumbnail

Key predictors of non-interventional mitral regurgitation improvement: Insights from the SHEBAHEART registry

Speaker: Doctor S. Elimeleh (Ramat Gan, IL)

Access
Abstract
Video
Like
Thumbnail

Granger causality analysis of factors driving atrial functional mitral regurgitation in atrial fibrillation

Speaker: Doctor T. Avram (Cluj Napoca, RO)

Access
Abstract
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (3) - Treatment and outcome of mitral valve regurgitation

Speakers: Doctor C. Riebel, Doctor D. Felbel, Doctor A. Vecerova, Doctor S. Elimeleh, Doctor T. Avram
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources